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[Abstract] An important component of this methodology is to assess the role of the tumor
microenvironment on tumor growth and survival. To tackle this problem, we have adapted the
original approach of Warburg (Warburg, 1923), by combining thin tissue slices with Stable
Isotope Resolved Metabolomics (SIRM) to determine detailed metabolic activity of human
tissues. SIRM enables the tracing of metabolic transformations of source molecules such as
glucose or glutamine over defined time periods, and is a requirement for detailed pathway
tracing and flux analysis. In our approach, we maintain freshly resected tissue slices (both
cancerous and non- cancerous from the same organ of the same subject) in cell culture media,
and treat with appropriate stable isotope-enriched nutrients, e.g.

13

C6-glucose or

13

C5,

15

N2-glutamine. These slices are viable for at least 24 h, and make it possible to eliminate

systemic influence on the target tissue metabolism while maintaining the original 3D cellular
architecture. It is therefore an excellent pre-clinical platform for assessing the effect of
therapeutic agents on target tissue metabolism and their therapeutic efficacy on individual
patients (Xie et al., 2014; Sellers et al., 2015).

Materials and Reagents

1. 25 ml T Flasks NC vent cap (SARSTEDT AG & Co, catalog number: 83.1810.002)
2. Portable container for liquid nitrogen (Nalgene plastic dewar) (Thermo Fisher Scientific,
catalog number: S34074C)
3. Sterile syringes and needles (Thermo Fisher Scientific, catalog number: 10142534)
4. Disposable transfer pipets (Samco fine tip, 1 ml) (VWR International, catalog number:
16001192)
5. Aerosol barrier tips for 1 ml and 1-200 μl (Thermo Fisher Scientific, catalog number:
02-707-42)
6. Screw cap plastic vials (2 ml) color coded caps (yellow, blue, green and red) (USA
Scientific, catalog number: 1420-8706, 1420-8701, 1420-8702 and 1420-9704)
7. Snap top plastic vials (1.5 ml) (USA Scientific, catalog number: 1615-5510)
8. 15 ml Falcon tubes (SARSTEDT AG & Co, catalog number: 62.554.205)
9. Dialyzed, sterile filtered fetal bovine serum (FBS) (free of serum metabolites),10-12
kDa (Atlanta Biochemical, catalog number: S12650)
10. Tracer examples:

13

C6-glucose,

13

C2-1, 2-glucose,
1

13

15

C5, N2-glutamine
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13

C6-glucose/D-glucose ([U- C], 99%) (Cambridge Isotope Laboratories,

catalog number: CLM-1396-CTM),

13

13

C2-1, 2 glucose/D-glucose (1, 2- C2, 99%)

(Cambridge Isotope Laboratories, catalog number: CLM-504),
13

L-glutamine ( C5, 99%;

15

13

15

C5,

N2-glutamine/

N2, 99%) (Cambridge Isotope Laboratories, catalog number:

CNLM-1275) or
13

Isotec: D- C6-glucose (Sigma-Aldrich, catalog number: 660663),
13

(Sigma-Aldrich, catalog number: 661422), L-Glutamine- C5,

13

C2-1, 2 glucose

15

N2 (Sigma-Aldrich,

catalog number: 607983)
12. Penicillin + Streptomycin: GE Healthcare PEN/STREP/FUNGIZONE 100 ml (Thermo
Fisher Scientific, catalog number: SV3007901)
13. Protocol

TM

10% Neutral buffered formalin (Thermo Fisher Scientific, catalog number:

032-059)
14. 25% (w/v) sterile filtered

13

C glucose (0.2 μm) in PBS (Stock solution-can be frozen,

aliquoted, and stored at 4 °C)
15. Liquid nitrogen
16. 70% ethanol (v/v)
17. 60% acetonitrile in water (v/v) (Sigma-Aldrich, catalog number: L010400)
18. Sodium chloride (NaCl) (Thermo Fisher Scientific, catalog number: S271-1)
19. Potassium chloride (KCl) (Sigma-Aldrich, catalog number: P9541)
20. Sodium phosphate dibasic (Na2HPO4) (Sigma-Aldrich, catalog number: S0876)
21. Potassium phosphate monobasic (KH2PO4) (Sigma-Aldrich, catalog number: P9791)
22. Amino acids: Glycine, L-Arginine, L-Asparagine, L-Aspartic acid, L-Cystine 2HCl,
L-Glutamic Acid, L-Glutamine, L-Histidine, L-Hydroxyproline, L-Isoleucine, L-Leucine,
L-Lysine

hydrochloride,

L-Methionine,

L-Phenylalanine,

L-Proline,

L-Serine,

L-Threonine, L-Tryptophan, L-Tyrosine disodium salt dehydrate, L-Valine
23. Vitamins: Biotin, Choline chloride, D-Calcium pantothenate, Folic Acid, i-Inositol,
Niacinamide, Para-Aminobenzoic Acid, Pyridoxine hydrochloride, Riboflavin, Thiamine
hydrochloride, Vitamin B12
.

24. Calcium nitrate [Ca(NO3)2 4H2O]
25. Magnesium sulfate (MgSO4)
26. Glutathione (reduced)
27. Phenol Red
28. Relevant medium (e.g. DMEM, RPMI, other defined medium) which lacks the tracer of
interest:
a. Dulbecco′s Modified Eagle′s Medium (DMEM) is a powder formula, free of glucose,
glutamine, pyruvate bicarbonate, and phenol red, giving considerable flexibility in
formulation for SIRM studies (Sigma-Aldrich, catalog number: D5030) (see
Recipes)

2
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b. RPMI 1640 is a liquid medium free of glucose and glutamine, but contains
bicarbonate and phenol red (MP Biomedicals, catalog number: 091646854) (see
Recipes)
29. 0.2 µm sterile filtered Phosphate Buffered Saline (PBS) (see Recipes)
30. Medium composition for 0.2%

13

C6-glucose, 2 mM

12

12

13

C-Gln (100 ml) (see Recipes)
15

31. Medium composition for 0.2% C glucose, 2 mM C5, N2-Gln (100 ml) (see Recipes)
Equipment

1. Class II Biosafety Hood
2. Trigas incubator with oxygen sensor and CO2 sensor (Thermo Fisher Scientific, model:
Hera cell 150i)
3. Sterilized rocker (Rotoshake Genie) (Scientific Industries, model: SI-1100)
4. Liquid nitrogen freezer for storage
5. K2-EDTA vacutainers (“purple top”) (BD, catalog number: 366643)
6. Refrigerated centrifuge with swing out rotor that can accept vacutainers [e.g. Sorvall
Legend X1R (Thermo Fisher Scientific, catalog number: 75-004-261) with a rotor
(Thermo Fisher Scientific, catalog number: 75003181)]
7. Pipettors (variable size ranges) (USA Scientific ErgoOne)
8. Weck Knife/Dermatome (George Tiemann & Co., catalog number: 222-5-523)
9. Weigh boats (Thermo Fisher Scientific, catalog number: 08732113 and 08732115)
10. 4-place balance (Thermo Fisher Scientific, Mettler-Toledo, catalog number: 0133525)
11. Ice bucket (Thermo Fisher Scientific, catalog number: 02-591-44)
12. Sharp dissecting scissors (Thermo Fisher Scientific, catalog number: 08940)
13. Excelta™ Plastic Tweezers (Thermo Fisher Scientific, catalog number: 17-456-066)
14. Digital camera

Procedure

A. Tissue procurement
All tissue must be procured under an IRB approved protocol. As live human tissue is
handled, all personnel must undergo and maintain biosafety, HIPAA and CITI certifications.
An overview of the whole process is given in Scheme 1.

3
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Scheme 1. FlowChart. Preop: Preoperative room; OR: Operating Room. The number of
thin slices to be taken depends on the size of the tumor. A piece of tissue is also flash
frozen in the OR, and additional tissue is placed in formalin for pathological analysis.

1. Blood samples provide overall information about the metabolic status of the individual
subjects, and the buffy coat can be used for extracting DNA or RNA for sequence
analysis.
2. A 10 ml sample of blood should be drawn preoperatively into a purple top vacutainer
(K2-EDTA) preoperatively. Other anticoagulants such as citrate or heparin should not
be used as they interfere with metabolic assays. A blood sample should also be drawn
perioperatively after resection. The blood is inverted twice to ensure dissolution of the
EDTA, and kept on ice immediately after blood draw. The blood should be separated
into packed red cells, buffy coat and plasma within 30 min by centrifuging at 3,500 x g
for 15 min at 4 °C in a swing out rotor.
+

Subsequent operations should be carried out in a BSL2 biosafety cabinet.
Note: We use the following color codes for storage: Red = whole blood, yellow =
plasma, green = buffy coat, blue = urine.
3. Plasma is aspirated into prechilled sterile 2 ml screw cap vials at 1 ml aliquots and flash
4
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frozen in liquid N2. Buffy coat is aspirated using a wide mouth plastic pipette into a 2 ml
screwcap vial and flash frozen in liquid N 2.
4. These experiments have been carried out on fresh slices of paired cancerous (CA) and
non-cancerous (NC) lung tissues resected from non-small cell lung cancer (Xie et al.,
2014) and pancreatic cancer patients. Upon resection, thin slices (0.5-1 mm thick) of
tissue are excised from the surface of visually non-necrotic or fibrotic tumor regions
using a Weck microtome in the Operating Room (OR), within approximately 5-10 min of
2

resection. Roughly 1 cm tissue is targeted (see Figure 1A). Control non-cancerous
tissue from a distant (>10 cm) region is obtained similarly. A pathologist on-site
inspects the CA and NC tissue specimens. Highly necrotic tissue is discarded.
5. At the same time, a small piece of bulk CA tissue should be placed in DMEM or other
appropriate medium kept room temperature for implantation into a recipient NSG
mouse as patient-derived xenograft or PDX. A small piece each of CA and NC tissues
is soaked in formalin for pathological examination or flash frozen in liquid N 2 for
image-based metabolic analysis.
6. Where tissue acquisition in the OR is impractical (such as colorectal or breast cancer
resections), the slices can be prepared in the pathology laboratory located close to the
OR. For comparison with freshly resected tissue, speed is essential as metabolism is
rapidly changing. Whenever feasible, tissue freezing should be performed in the OR.
7. The slices are placed into a drop of sterile PBS on two sterilized weigh boats to prevent
sticking and for spreading slices evenly. Each weight boat is pre-numbered for CA or
NC slices. The tissues on weight boats are then photographed. Each slice is rinsed
briefly with sterile PBS, blotted (twice) and then carefully placed into pre-numbered
(using ethanol-resistant marker pen) pre-tared (tare weight recorded) T25-flasks
containing 10 ml DMEM (or other relevant medium) with the appropriate tracer (e.g. 10
mM

13

C6-glucose or 2 mM

13

C5,

15

N2-glutamine), 10% dialyzed FBS (as needed), and

1x penicillin + streptomycin. The flasks with slices are brought to the culture room as
soon as possible and sprayed with 70% ethanol, and wiped dry before placing them in
the Biosafety hood.
8. Pipet 200 μl culture media from each flask into 1.5 ml snap-cap tubes (t0-time zero
media samples). Centrifuge for 10 min at 10,000 x g at 4 °C to remove tissue debris.
Transfer 100 μl to tared 1.5 μl snap-cap tube for metabolite extraction and weigh the
media transferred. Transfer the remaining media to a 1.5 ml screw-cap tube for
long-term storage at -80 °C.
9. Weigh flasks in a 2-place balance inside the Biosafety hood and record weight on the
flask.
10. Transfer flasks to a CO2 incubator containing a rocker set to low amplitude rocking
(sufficient to ensure that the liquid moves over the slices without non-laminar flow)
Figure 1B) set to 37 °C and 5% CO2, with oxygen set to the desired level (e.g. 20%,
1%).
5
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11. The flasks are continuously and gently rocked for 24 to 48 h for gas exchange and to
maintain constant nutrient supplies at the tissue surface, while avoiding local buildup of
waste products such as acids.
12. As needed, the medium can be refreshed every 12 h, and sampled at 0, 6, 12, 24…. h
for analysis of nutrient uptake and waste production. The flasks are weighed before
and after each medium sampling point and flask weights are recorded on the flasks.

B. Tissue Harvesting
1. After 24 h incubation, weigh flasks.
2. Place flasks on ice immediately after removing from the incubator to minimize further
metabolism. Up to 6 flasks can be harvested at a time. Keep tissue slices on ice as
much as possible during harvest.
3. Using a transfer pipet, aspirate and transfer the conditioned media into 15-ml conical
centrifuge tubes.
4. Centrifuge media for 15 min at 3,500 to 4,690 x g, 4 °C to remove any particulates and
debris.
5. Pipet 100 μl T24 media supernatant into 1.5-ml snap-cap tubes for metabolite
extraction.
6. Pipet 1 ml media aliquot into 2-ml screw-cap tubes for long-term storage at -80 °C.
7. The remaining medium is stored separately in a 7 ml vial at -80 °C for purposes such as
exosome isolation.
8. Invert and tap the flask to move the tissue slices into the cap or neck region of the flask
for retrieval. Keep flask inverted on ice.
9. Wash tissue slices 3x consecutively in ice-cold 10 ml cold PBS each in a 50 ml beaker.
10. Blot dry the tissue slices on Kimwipe and photograph the flattened slice on a small
weigh boat.
11. Weigh the whole tissue slice on small weigh boats and record the weight.
12. Split a very small piece for preservation in 1 ml buffered formalin in a 1.5 ml snap-cap
tube for histology. The remaining tissue slice is split evenly and each piece should
weigh no more than 20-30 mg by wet weight to facilitate tissue homogenization and
extraction efficiency. Immediately after weighing, each piece is flash-frozen in liq. N2
and placed in a pre-liq. N2 chilled 1.5-ml snap-cap tube for long-term storage at -80 °C.
13. After 6-8 h in formalin, replace the formalin with 70% ethanol for the tissue pieces
prepared for histology.
14. Homogenize tissues in cold 60% acetonitrile (v/v) and extract tissue homogenates for
metabolite analyses according to standardized protocols (Fan, 2012; Fan, 2010) before
analyses using stable isotope-resolving analytical techniques (e.g. NMR and MS) (Fan,
2012) (Figure 1C) (Lane et al., 2008).
15. This Protocol describes the procedure for stable isotope labeling of thin tissue slices.
SIRM analysis involves the quantification of isotopomers (by NMR) and isotopologues
6

http://www.bio-protocol.org/e1730

Vol 6, Iss 3, Feb 05, 2016

(MS) that result from metabolic transformations of source molecules (e.g.
or

13

C,

15

13

C glucose

N Glutamine) in cells or tissue (Figure 1C). The techniques of SIRM analysis

by NMR and mass spectrometry are described in detail in Sellers et al. (2015); Lane et
al. (2008) and Fan et al. (2012).

Representative data

A

C

B

Ex vivo tissue slices

Figure 1 Example ex vivo tissue slice experiment. A. Example thin slices of
non-cancerous lung tissue (NC, left) adjacent to a lung adenocarcinoma (CA, right); B.
1

13

T25-flasks on a rocker inside a CO2 incubator; C. Representative 1D H{ C} HSQC NMR
spectra (recorded at 14.1 T, 15 °C) of extracts of CA versus NC lung slices from an non
small cell lung cancer (NSCLC) patient incubated for 24 h in the presence of 10 mM
13

C6-glucose. The tissue slices were pulverized and extracted as described (Sellers et al.,

2015; Fan, 2012) which produces three phases- an upper aqueous phase containing polar
metabolites, a lower organic phase containing non-polar metabolites (mainly lipids) and an
interfacial phase that contains protein. Here the upper phase was lyophilized and
redissolved in a phosphate buffer containing 50% D 2O and 25 nmol DSS-d6 that serves
both as a chemical shift reference and a concentration standard (Fan and Lane, 2013). The
HSQC spectrum detects protons attached directly to

13

C, and thus gives a readout of the

13

metabolites that have incorporated C from the source molecule (glucose in this instance).
The spectra of cancer and non-cancerous tissues are recorded under identical conditions,
7

http://www.bio-protocol.org/e1730

Vol 6, Iss 3, Feb 05, 2016

and the absolute intensities are normalized to the tissue protein weight. Peak areas were
determined using peak fitting functions in MNOVA (Mestrelab Research, Santiago de
Compostela, Spain)
Enhanced production of various
including

13

13

C labeled metabolites in the CA tissue slice is evident,

C-lactate (Lac), which is consistent with the Warburg effect or accelerated

glycolysis in tumor tissues (Warburg, 1956).
Notes

1. These procedures have been tested on freshly resected NSCLC and pancreatic
cancer, as well as in patient derived mouse xenografts. Other tissues may need
experimentation with the composition of the medium and length of incubation period for
metabolic viability.
2. Larger or inflammatory tumors may have substantial areas of necrosis or fibrosis that
need to be avoided.
3. A Weck microtome is hand held, but with practice the surgeons can reproducibly
produce slices < 1 mm thick. Slice thickness is easily estimated by measuring the area
of the slice from a photograph and from the wet weigh as the average thickness h =
weight/area.
4. Some tumors are highly mucilaginous and are more difficult to slice reproducibly.
5. An alternative to a Weck microtome is a vibrating microtome, which can reproducibly
10

generate thinner slices from firm but not soft tissues (cf ), but is much slower. Very thin
slices (100-200 μm) may show a proportionately larger wounding response and are
more fragile.
6. As many tumors are heterogeneous not only in the cancer/stromal content in different
regions of the tumor but also in terms of genetics, it is advisable to obtain multiple slices
from the tumor to cover this heterogeneity. This also makes histopathological
examination of each slice critically important.
7. The margins of some tumors are not obvious without pathological examination.
Tissue proximal to the tumor as well as distal from the tumor should be sampled for
comparison.

Recipes

1. DMEM and RPMI Medium 1640
For SIRM studies, the glutamine or glucose free version of the medium should be used,
13

with supplementation of the appropriate concentration of C-enriched precursors in the
base medium.

8
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Molecular Concentration Molarity (mM) Molarity (mM)
Weight

(mg/L)

RPMI

DMEM

Amino Acids
Glycine

75

10

0.133

0.40

L-Arginine

174

200

1.15

0.483

L-Asparagine

132

50

0.379

-

L-Aspartic acid

133

20

0.150

-

L-Cystine 2HCl

313

65

0.208

0/0.2

L-Glutamic Acid

147

20

0.136

-

L-Glutamine

146

300

2.05

2

L-Histidine

155

15

0.0968

0.27

L-Hydroxyproline

131

20

0.153

-

L-Isoleucine

131

50

0.382

0.8

L-Leucine

131

50

0.382

0.8

L-Lysine hydrochloride

146

40

0.274

1.0

L-Methionine

149

15

0.101

0.2

L-Phenylalanine

165

15

0.0909

0.4

L-Proline

115

20

0.174

-

L-Serine

105

30

0.286

0.4

L-Threonine

119

20

0.168

0.8

L-Tryptophan

204

5

0.0245

0.078

29

0.111

0.4

117

20

0.171

0.8

Biotin

244

0.2

0.000820

Choline chloride

140

3

0.0214

0.0285

D-Calcium pantothenate

477

0.25

0.000524

0.008

Folic Acid

441

1

0.00227

0.009

i-Inositol

180

35

0.194

.04

L-Tyrosine disodium salt 261
dihydrate
L-Valine
Vitamins

9
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Niacinamide

122

1

0.00820

0.033

Para-Aminobenzoic Acid

137

1

0.00730

Pyridoxine hydrochloride

206

1

0.00485

.019

Riboflavin

376

0.2

0.000532

.001

Thiamine hydrochloride

337

1

0.00297

.012

Vitamin B12

1,355

0.005

0.0000037

-

100

0.424

48.84

0.407

400

5.33

2,000

23.81

6,000

103.45

1,512

5.64

Inorganic Salts
Calcium

nitrate 236
.

(Ca(NO3)2 4H2O)
Magnesium

Sulfate 120

(MgSO4) (anhyd.)
Potassium Chloride (KCl)
Sodium

75

Bicarbonate 84

44

(NaHCO3)
Sodium Chloride (NaCl)

58

Sodium Phosphate dibasic 268
.
(Na2HPO4 7H2O)

Other Components
Glutathione (reduced)

307

1

0.00326

Phenol Red

376.4

5

0.0133

2. 10x PBS
Sources of reagents are given in the Materials Section
80 g NaCl
2 g KCl
14.4 g Na2HPO4 anhydrous
2.4 g KH2PO4 anhydrous
Dissolve in 950 ml 18 MOhm water, pH to 7.4, make to 1 L, sterile filter (0.2 μm)
3. Medium composition for 0.2%

13

C6-glucose, 2 mM

12

C-Gln (100 ml)

89.2 ml base medium minus tracer (e.g. glucose-free version) (89% concentration of
nutrients)
10 ml sterile filtered dialyzed FBS (10% FBS)
0.8 ml 25% sterile filtered

13

C6 glucose (0.2 µm) in PBS (10.75 mM glucose final)

1 ml 100x streptomycin/penicillin stock
4. Medium composition for 0.2%

12

C glucose, 2 mM
10

13

C5 ,

15

N2-Gln (100 ml)

http://www.bio-protocol.org/e1730
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88 ml base medium minus tracer (glutamine-free version) (88% concentration of all
nutrients)
10 ml sterile filtered dialyzed FBS (10% FBS)
1 ml 0.2 M sterile filtered

13

C5,

15

N2-glutamine (0.2 µm) in PBS (2 mM final)

1 ml 100x streptomycin/penicillin stock
For hormone sensitive tissues, activated carbon-stripped FBS may be used.
For other concentrations of FBS, adjust the volumes of the FBS and base medium
accordingly.
Note: Glutamine stock should be made fresh or stored at -20 °C in small aliquots to
avoid repeated freeze and thawing. It forms pyroglutamate on storage in solution even
at neutral pH at higher temperatures.

Acknowledgments

This work was supported in part by the following grants: NIH P01 CA163223-01A1, NIH
5R01ES022191-04, NIH 3R01ES022191-04S1, NIH 1U24DK097215-01A1, and the
Kentucky Challenge for Excellence. This protocol has been developed based on work
described in Xie et al. (2014); Sellers et al. (2015) and Bousamra et al. (2012). The authors
declare no conflicts of interest.

References

1. Bousamra, M., Day, J., Fan, T. W., Higashi, R. M., Kloecker, G., Lane, A. N. and Miller,
D. M. (2012). Clinical aspects of metabolomics. In: The Handbook of Metabolomics.
Humana, Vol. 17.
2. Fan, T. W. (2012). Considerations of sample preparation for metabolomics
investigation. Handbook of Metabolomics 17.
3. Fan, T. W. (2010). Metabolomics-edited transcriptomics analysis (meta). In: McQueen,
C. A. (ed). Comprehensive Toxicology. Academic Press Vol. 2 685-706.
4. Fan, T. W. and Lane, A. N. (2013). Assignment strategies for NMR resonances in
metabolomics research. In: Lutz, N., Sweedler, J. V. and Weevers, R. A. (eds).
Methodologies

for

Metabolomics:

Experimental

Strategies

and

Techniques.

Cambridge University Press.
5. Fan, T. W., Lorkiewicz, P. K., Sellers, K., Moseley, H. N., Higashi, R. M. and Lane, A. N.
(2012). Stable isotope-resolved metabolomics and applications for drug development.
Pharmacol Ther 133(3): 366-391.
6. Lane, A. N., Fan, T. W. and Higashi, R. M. (2008). Isotopomer-based metabolomic
analysis by NMR and mass spectrometry. Methods Cell Biol 84: 541-588.
7. Sellers, K., Fox, M. P., Bousamra, M., 2nd, Slone, S. P., Higashi, R. M., Miller, D. M.,
Wang, Y., Yan, J., Yuneva, M. O., Deshpande, R., Lane, A. N. and Fan, T. W. (2015).

11

http://www.bio-protocol.org/e1730

Vol 6, Iss 3, Feb 05, 2016

Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. J Clin Invest
125(2): 687-698.
8. Warburg, O. (1923). Versuche an überlebendem Carcinomgewebe (Methoden).
Biochem Zeitschr 142, 317-333.
9. Warburg, O. (1956). On the origin of cancer cells. Science 123(3191): 309-314.
10. Xie, H., Hanai, J., Ren, J. G., Kats, L., Burgess, K., Bhargava, P., Signoretti, S., Billiard,
J., Duffy, K. J., Grant, A., Wang, X., Lorkiewicz, P. K., Schatzman, S., Bousamra, M.,
2nd, Lane, A. N., Higashi, R. M., Fan, T. W., Pandolfi, P. P., Sukhatme, V. P. and Seth,
P. (2014). Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor
progression in mouse models of lung cancer and impacts tumor-initiating cells. Cell
Metab 19(5): 795-809.
11. Zimmermann, M., Sebastian Lange, S., Lampe, J., Smirnow, I., Bitzer, M. and Lauer,
U. M. (2012). Precision-cut slices of normal and tumorous liver tissues generated with
the Leica VT1200 S vibrating blade microtome. In: T̈bingen, M. U. (ed).
LeicaBiosystems, Vol. 95.8807 Rev B - Order no. 1495.8807 T̈bingen.

12

